Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation.
After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow.
In Oncology, we are building on impressive pre-clinical data with Oncolytic Bacteria lead candidate AUP-55, which shows increased survival in Ovarian Cancer and peritoneal carcinomatosis.
Our pipeline also includes Inflammation, at discovery stage.
Company Details
- Employees
- 18
- Founded
- -
- Address
- Microkatu 1, Kuopio,70210,finland
- Phone
- 358458433550
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aurealispharma.com
- Keywords
- Cell and gene therapy, Recombinant Live Biotherapeutic, Chronic wounds, Oncology, Advanced Therapy Medicinal Product, Inflammation, Oncolytic Bacteria.
- HQ
- Kuopio
Aurealis Therapeutics Questions
Aurealis Therapeutics's helpline number is 358458433550
Aurealis Therapeutics's website is aurealispharma.com
Aurealis Therapeutics's LinkedIn profile is https://fi.linkedin.com/company/aurealis-ltd
Aurealis Therapeutics has
18 employees.
View email and phone details for 18
employees at Aurealis Therapeutics.
Aurealis Therapeutics's industry is
Biotechnology Research
Aurealis Therapeutics's top competitors are
Alentis Therapeutics,
Shape Biopharmaceuticals Inc.,
T3 Pharmaceuticals Ag,
Araris Biotech Ag,
Gio Therapeutics,
Nemis Technologies,
Charles River Laboratories,
Cellestia Biotech,
Versameb Ag,
Nbe-Therapeutics Ag.
Aurealis Therapeutics's categories are Biotechnology Research
Aurealis Therapeutics's founding year is 2015
